We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Stanley Black & Decker
SWK
$13.8B
| $761K | 0.01% |
7,703
| – | – |
2013 Q2
42 quarters
|
|
302
Aon
AON
$61.5B
| $752K | 0.01% |
2,600
| – | – |
2019 Q1
19 quarters
|
|
303
Altria Group
MO
$124B
| $746K | 0.01% |
18,102
-1,301
| -7% | -$53.8K |
2013 Q2
42 quarters
|
|
304
LXP Industrial Trust
LXP
$3.6B
| $743K | 0.01% |
14,572
-4,860
| -25% | -$212K |
2023 Q2
2 quarters
|
|
305
Blackstone
BX
$85.5B
| $742K | 0.01% |
5,575
+801
| +17% | +$86.7K |
2019 Q3
17 quarters
|
|
306
SPDR Gold Trust
GLD
$140B
| $741K | 0.01% |
3,870
-5
| -0.1% | -$916 |
2021 Q4
8 quarters
|
|
307
Hershey
HSY
$33.6B
| $741K | 0.01% |
4,023
-43
| -1% | -$8.15K |
2013 Q2
42 quarters
|
|
308
CRISPR Therapeutics
CRSP
$4.84B
| $714K | 0.01% |
11,100
| – | – |
2021 Q4
8 quarters
|
|
309
iShares US Industrials ETF
IYJ
$1.92B
| $714K | 0.01% |
6,224
-110
| -2% | -$11.5K |
2020 Q2
14 quarters
|
|
310
iShares Russell 1000 Growth ETF
IWF
$126B
| $680K | 0.01% |
8,936
-296
| -3% | -$20.9K |
2013 Q2
42 quarters
|
|
311
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.7B
| $657K | 0.01% |
6,555
-250
| -4% | -$25K |
2014 Q2
38 quarters
|
|
312
iShares Core S&P Total US Stock Market ETF
ITOT
$96.3B
| $634K | 0.01% |
5,997
+640
| +12% | +$62.7K |
2020 Q2
14 quarters
|
|
313
Moody's
MCO
$83.3B
| $634K | 0.01% |
1,624
-575
| -26% | -$200K |
2019 Q3
17 quarters
|
|
314
Invesco S&P 500 Low Volatility ETF
SPLV
$7.13B
| $633K | 0.01% |
10,120
| – | – |
2022 Q2
6 quarters
|
|
315
T-Mobile US
TMUS
$167B
| $630K | 0.01% |
3,963
+163
| +4% | +$24.1K |
2023 Q2
2 quarters
|
|
316
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.71B
| $617K | 0.01% |
6,488
+270
| +4% | +$24.7K |
2018 Q4
20 quarters
|
|
317
Everest Group
EG
$15B
| $616K | 0.01% |
1,747
| – | – |
2019 Q2
18 quarters
|
|
318
LCNB Corp
LCNB
$271M
| $610K | 0.01% |
37,397
-3
| -0% | -$44 |
2022 Q1
7 quarters
|
|
319
Fifth Third Bancorp Depositary Shares 4.95% Preferred Stock Series K
FITB.PRK
$174M
| $602K | 0.01% |
25,970
-3,290
| -11% | -$69.4K |
2021 Q4
8 quarters
|
|
320
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.74B
| $600K | 0.01% |
14,819
-21,340
| -59% | -$766K |
2022 Q1
7 quarters
|
|
321
Lennox International
LII
$12.3B
| $595K | 0.01% |
1,326
+1,317
| +14,633% | +$525K |
2022 Q2
6 quarters
|
|
322
PayPal
PYPL
$48.3B
| $594K | 0.01% |
9,414
+740
| +9% | +$42.4K |
2019 Q2
18 quarters
|
|
323
iShares 1-10 Year U.S. Aggregate Bond ETF
AGGM
$130M
| $588K | 0.01% |
5,580
+190
| +4% | +$19.2K |
2022 Q4
4 quarters
|
|
324
Ulta Beauty
ULTA
$25.3B
| $586K | 0.01% |
1,203
+7
| +0.6% | +$2.95K |
2023 Q2
2 quarters
|
|
325
First Citizens BancShares
FCNCA
$23.7B
| $582K | 0.01% |
405
| – | – |
2013 Q2
42 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.